Healthcare provider profile · identity verified

Jarod D Snyder, M.D.

Family Practice · SENECA, KS · NPI 1992063408

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	569	148
Losartan Potassium	Losartan Potassium	433	106
Levothyroxine Sodium	Levothyroxine Sodium	327	68
Amlodipine Besylate	Amlodipine Besylate	219	56
Furosemide	Furosemide	188	44
Gabapentin	Gabapentin	184	37
Pantoprazole Sodium	Pantoprazole Sodium	183	48
Hydrochlorothiazide	Hydrochlorothiazide	181	49
Lisinopril	Lisinopril	170	40
Metformin Hcl	Metformin Hcl	164	39
Omeprazole	Omeprazole	164	38
Tamsulosin Hcl	Tamsulosin Hcl	156	44
Metoprolol Succinate	Metoprolol Succinate	144	34
Warfarin Sodium	Warfarin Sodium	136	18
Potassium Chloride	Potassium Chloride	119	31
Sertraline Hcl	Sertraline Hcl	116	30
Eliquis	Apixaban	111	18
Meloxicam	Meloxicam	111	31
Baclofen	Baclofen	97	12
Trazodone Hcl	Trazodone Hcl	97	20
Spironolactone	Spironolactone	94	22
Simvastatin	Simvastatin	85	22
Allopurinol	Allopurinol	84	17
Finasteride	Finasteride	81	17
Metoprolol Tartrate	Metoprolol Tartrate	79	12
Fluticasone Propionate	Fluticasone Propionate	78	29
Duloxetine Hcl	Duloxetine Hcl	77	23
Famotidine	Famotidine	60	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	60	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	17
Mirtazapine	Mirtazapine	59	13
Trulicity	Dulaglutide	57	suppressed
Carvedilol	Carvedilol	50	17
Buspirone Hcl	Buspirone Hcl	49	13
Metformin Hcl Er	Metformin Hcl	47	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	11
Albuterol Sulfate Hfa	Albuterol Sulfate	43	14
Tramadol Hcl	Tramadol Hcl	43	15
Ozempic	Semaglutide	41	suppressed
Donepezil Hcl	Donepezil Hcl	40	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	11
Alendronate Sodium	Alendronate Sodium	38	11
Azithromycin	Azithromycin	37	19
Atenolol	Atenolol	36	suppressed
Xarelto	Rivaroxaban	36	suppressed
Celecoxib	Celecoxib	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Lorazepam	Lorazepam	31	suppressed
Meclizine Hcl	Meclizine Hcl	31	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Ondansetron Odt	Ondansetron	30	15
Alprazolam	Alprazolam	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Cephalexin	Cephalexin	29	29
Rosuvastatin Calcium	Rosuvastatin Calcium	29	12
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	28	suppressed
Terazosin Hcl	Terazosin Hcl	28	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	27	suppressed
Klor-Con M20	Potassium Chloride	27	suppressed
Methylprednisolone	Methylprednisolone	26	24
Mounjaro	Tirzepatide	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	18
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Lovastatin	Lovastatin	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Torsemide	Torsemide	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Mupirocin	Mupirocin	19	12
Doxycycline Hyclate	Doxycycline Hyclate	18	15
Levetiracetam	Levetiracetam	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Prednisone	Prednisone	16	15
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Insulin Lispro	Insulin Lispro	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Lacosamide	Lacosamide	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Asmanex	Mometasone Furoate	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Klor-Con 10	Potassium Chloride	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Nystatin	Nystatin	13	suppressed
Clonazepam	Clonazepam	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Moexipril Hcl	Moexipril Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error